CardioSignal by Precordior Revenue
Medical Equipment Manufacturing • 
Turku, Southwest Finland, Finland • 21-50 Employees
CardioSignal by Precordior revenue & valuation
| Annual revenue | $2,652,205 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $8,500,000 |
| Total funding | $12,700,000 |
Key Contacts at CardioSignal by Precordior
Kamal Jafarian Dehkordi
Data Analysis Director
Blaz Mrevlje
Medical Director
Juuso Blomster
Chief Executive Officer
Heini Saari
Product Director
Ville Ingman
Director, Sales And Business Intelligence
Company overview
| Headquarters | Aurakatu 6, Turku, Southwest Finland 20100, FI |
| Phone number | +358102021200 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
CardioSignal by Precordior Email Formats
CardioSignal by Precordior uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cardiosignal.com), used 52.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@cardiosignal.com | 52.2% |
{first initial}.{last name} | j.doe@cardiosignal.com | 47.8% |
About CardioSignal by Precordior
CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
CardioSignal by Precordior has 18 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore CardioSignal by Precordior's funding history, including investment rounds, total capital raised, and key backers.
CardioSignal by Precordior Tech Stack
Discover the technologies and tools that power CardioSignal by Precordior's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Cookie compliance
Video players
JavaScript libraries
Maps
Miscellaneous
JavaScript libraries
Analytics
Webmail
JavaScript frameworks
United Kingdom
United States
Saudi Arabia
Israel
Frequently asked questions
4.8
40,000 users
